Global Surgical Sphincteroplasty Market Size Study, by Type (Surgical, Non-Surgical), and Regional Forecasts 2022-2032

Description

Global Surgical Sphincteroplasty Market is valued at approximately USD 1.48 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 6.67% over the forecast period 2024-2032. Surgical sphincteroplasty is a specialized procedure aimed at repairing damaged or weakened anal sphincters, which often result from childbirth, trauma, or various conditions causing fecal incontinence. This intricate surgery involves reapproximating the torn ends of the sphincter muscle to restore its functionality. Typically performed under general or regional anesthesia, the procedure might necessitate a hospital stay. Postoperative care is crucial and includes pain management, dietary modifications, and pelvic floor exercises to facilitate recovery and enhance bowel control, significantly improving the patient's quality of life.

The growth of the surgical sphincteroplasty market is primarily driven by the rising incidence of fecal incontinence, advancements in surgical techniques, and increasing awareness and diagnosis rates. Additionally, the expanding geriatric population and technological innovations in medical devices play a significant role in propelling market growth. Moreover, substantial opportunities are present in emerging markets within developing countries, ongoing research and development in minimally invasive techniques, and potential collaborations and partnerships. Moreover, patient education and awareness programs, along with government initiatives aimed at improving healthcare, provide promising avenues for market growth. However, several restraints exist, including the high cost of surgery, risks of postoperative complications, and the limited availability of specialized surgeons. Alternative non-surgical treatments and stringent regulatory requirements further challenge market expansion.

Regionally, North America dominated the surgical sphincteroplasty market, accounting for the largest revenue share in 2023. This dominance is attributed to the improved healthcare infrastructure and the presence of leading market players in the region. The market is expected to maintain its leading position due to ongoing clinical research focused on establishing effective treatment options for anal incontinence. Furthermore, the Asia Pacific region is projected to witness the highest CAGR during the forecast period owing to growing aging population, increased adoption of cost-effective surgeries such as sphincteroplasty, and enhanced government healthcare expenditure are expected to drive market growth in this region.

Major market players included in this report are:

Medtronic plc
Hill-Rom Services, Inc.
McKesson
B. Braun AG
Becton, Dickinson and Company
Novo Surgical, Inc.
Surgical Holdings
Pelvalon
Salix Pharmaceutical Inc.
Johnson & Johnson
Coloplast Corp.
ConvaTec Group Plc
Cook Medical
Boston Scientific Corporation
Smith & Nephew plc

The detailed segments and sub-segment of the market are explained below:

By Type:

Surgical
Non-Surgical

By Region:

North America:

U.S.
Canada

Europe:

UK
Germany
France
Spain
Italy
ROE

Asia Pacific:

China
India
Japan
Australia
South Korea
RoAPAC

Latin America:

Brazil
Mexico
RoLA

Middle East & Africa:

Saudi Arabia
South Africa
RoMEA

Years considered for the study are as follows:

Historical year - 2022
Base year - 2023
Forecast period - 2024 to 2032

Key Takeaways:

Market Estimates & Forecast for 10 years from 2022 to 2032.
Annualized revenues and regional level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market

Chapter 1. Global Surgical Sphincteroplasty Market Executive Summary

1.1. Global Surgical Sphincteroplasty Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
- 1.3.1. By Type
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion

Chapter 2. Global Surgical Sphincteroplasty Market Definition and Research Assumptions

2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
- 2.3.1. Inclusion & Exclusion
- 2.3.2. Limitations
- 2.3.3. Supply Side Analysis
  - 2.3.3.1. Availability
  - 2.3.3.2. Infrastructure
  - 2.3.3.3. Regulatory Environment
  - 2.3.3.4. Market Competition
  - 2.3.3.5. Economic Viability (Consumer's Perspective)
- 2.3.4. Demand Side Analysis
  - 2.3.4.1. Regulatory Frameworks
  - 2.3.4.2. Technological Advancements
  - 2.3.4.3. Environmental Considerations
  - 2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates

Chapter 3. Global Surgical Sphincteroplasty Market Dynamics

3.1. Market Drivers
- 3.1.1. Rising Incidence of Fecal Incontinence
- 3.1.2. Advancements in Surgical Techniques
- 3.1.3. Increasing Awareness and Diagnosis Rates
3.2. Market Challenges
- 3.2.1. High Cost of Surgery
- 3.2.2. Risk of Postoperative Complications
- 3.2.3. Limited Availability of Specialized Surgeons
3.3. Market Opportunities
- 3.3.1. Emerging Markets in Developing Countries
- 3.3.2. Research and Development in Minimally Invasive Techniques
- 3.3.3. Potential Collaborations and Partnerships

Chapter 4. Global Surgical Sphincteroplasty Market Industry Analysis

4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
- 4.1.6. Futuristic Approach to Porter's 5 Force Model
- 4.1.7. Porter's 5 Force Impact Analysis
4.2. PESTEL Analysis
- 4.2.1. Political
- 4.2.2. Economical
- 4.2.3. Social
- 4.2.4. Technological
- 4.2.5. Environmental
- 4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Surgical Sphincteroplasty Market Size & Forecasts by Type 2022-2032

5.1. Segment Dashboard
5.2. Global Surgical Sphincteroplasty Market: Type Revenue Trend Analysis, 2022 & 2032 (USD Billion)
- 5.2.1. Surgical
- 5.2.2. Non-Surgical

Chapter 6. Global Surgical Sphincteroplasty Market Size & Forecasts by Region 2022-2032

6.1. North America Surgical Sphincteroplasty Market
- 6.1.1. U.S. Surgical Sphincteroplasty Market
  - 6.1.1.1. Type breakdown size & forecasts, 2022-2032
- 6.1.2. Canada Surgical Sphincteroplasty Market
6.2. Europe Surgical Sphincteroplasty Market
- 6.2.1. UK Surgical Sphincteroplasty Market
- 6.2.2. Germany Surgical Sphincteroplasty Market
- 6.2.3. France Surgical Sphincteroplasty Market
- 6.2.4. Spain Surgical Sphincteroplasty Market
- 6.2.5. Italy Surgical Sphincteroplasty Market
- 6.2.6. Rest of Europe Surgical Sphincteroplasty Market
6.3. Asia-Pacific Surgical Sphincteroplasty Market
- 6.3.1. China Surgical Sphincteroplasty Market
- 6.3.2. India Surgical Sphincteroplasty Market
- 6.3.3. Japan Surgical Sphincteroplasty Market
- 6.3.4. Australia Surgical Sphincteroplasty Market
- 6.3.5. South Korea Surgical Sphincteroplasty Market
- 6.3.6. Rest of Asia Pacific Surgical Sphincteroplasty Market
6.4. Latin America Surgical Sphincteroplasty Market
- 6.4.1. Brazil Surgical Sphincteroplasty Market
- 6.4.2. Mexico Surgical Sphincteroplasty Market
- 6.4.3. Rest of Latin America Surgical Sphincteroplasty Market
6.5. Middle East & Africa Surgical Sphincteroplasty Market
- 6.5.1. Saudi Arabia Surgical Sphincteroplasty Market
- 6.5.2. South Africa Surgical Sphincteroplasty Market
- 6.5.3. Rest of Middle East & Africa Surgical Sphincteroplasty Market

Chapter 7. Competitive Intelligence

7.1. Key Company SWOT Analysis
7.2. Top Market Strategies
7.3. Company Profiles
- 7.3.1. Medtronic plc
  - 7.3.1.1. Key Information
  - 7.3.1.2. Overview
  - 7.3.1.3. Financial (Subject to Data Availability)
  - 7.3.1.4. Product Summary
  - 7.3.1.5. Market Strategies
- 7.3.2. Hill-Rom Services, Inc.
- 7.3.3. McKesson
- 7.3.4. B. Braun AG
- 7.3.5. Becton, Dickinson and Company
- 7.3.6. Novo Surgical, Inc.
- 7.3.7. Surgical Holdings
- 7.3.8. Pelvalon
- 7.3.9. Salix Pharmaceutical Inc.
- 7.3.10. Johnson & Johnson
- 7.3.11. Coloplast Corp.
- 7.3.12. ConvaTec Group Plc
- 7.3.13. Cook Medical
- 7.3.14. Boston Scientific Corporation
- 7.3.15. Smith & Nephew plc

Chapter 8. Research Process

8.1. Research Process
- 8.1.1. Data Mining
- 8.1.2. Analysis
- 8.1.3. Market Estimation
- 8.1.4. Validation
- 8.1.5. Publishing
8.2. Research Attributes